Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1
ATALANTE-1 study group
Research output: Contribution to journal › Article › peer-review
42Scopus
citations
Fingerprint
Dive into the research topics of 'Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1'. Together they form a unique fingerprint.